Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
32 35 Search
2025
Genetics and Epigenetics of Genitourinary Diseases
2024
Cigarette smoking combined with genetic variation regulates the m6A methylation of CRNKL1 and is associated with bladder cancer risk
Environmental Toxicology
2024
Glycoprotein nonmetastatic melanoma protein B impacts the malignant potential of bladder cancer cells through its hem‐immunoreceptor tyrosine‐based activation motif
Pathology International
2024
Unveiling Anoikis‐related genes: A breakthrough in the prognosis of bladder cancer
The Journal of Gene Medicine
2024
Transcriptome profiling research in urothelial cell carcinoma
Applied Research
2024
The Role of Emodin in the Treatment of Bladder Cancer Based on Network Pharmacology and Experimental Verification
Combinatorial Chemistry & High Throughput Screening
2023
Li-Fraumeni syndrome in the setting of re-occurring malignancies after 27 years of remission: a case report
Annals of Medicine & Surgery
2023
Metabolic Modulation of Intracellular Ammonia via Intravesical Instillation of Nanoporter‐Encased Hydrogel Eradicates Bladder Carcinoma
Advanced Science
2023
The utilisation of digital droplet PCR to enhance the diagnosis of bladder and pancreaticobiliary tumours in cytology specimens
Diagnostic Cytopathology
2023
FAM193A is a positive regulator of p53 activity
Cell Reports
2023
Methylenetetrahydrofolate Reductase C677T (rs1801133) Polymorphism Is Associated with Bladder Cancer in Asian Population: Epigenetic Meta-Analysis as Precision Medicine Approach
Cancers
2023
Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer
Frontiers in Oncology
2022
Investigation of prognostic biomarkers in patients with urothelial carcinoma treated with platinum-based regimens
Urologic Oncology: Seminars and Original Investigations
2022
Study on Molecular Information Intelligent Diagnosis and Treatment of Bladder Cancer on Pathological Tissue Image
Frontiers in Medicine
2022
The Prognostic Role of CDK9 in Bladder Cancer
Cancers
2022
Effective Radiosensitization of Bladder Cancer Cells by Pharmacological Inhibition of DNA-PK and ATR
Biomedicines
2022
A meta-analysis on the susceptibility to the development of bladder cancer in the presence of DNMT3A, DNMT3B, and MTHFR gene polymorphisms
African Journal of Urology
2021
Comparative Cancer Cell Signaling in Muscle-Invasive Urothelial Carcinoma of the Bladder in Dogs and Humans
Biomedicines
2021
DNA damaging agents and DNA repair: From carcinogenesis to cancer therapy
Cancer Genetics
2021
An Unusual Location for a Nonurachal Bladder Adenocarcinoma
Case Reports in Urology
2021
Development and Validation of a Hypoxia-Related Signature for Predicting Survival Outcomes in Patients With Bladder Cancer
Frontiers in Genetics
2021
A hypoxia related long non-coding RNA signature could accurately predict survival outcomes in patients with bladder cancer
Bioengineered
2021
Evaluation of FGFR1 as a diagnostic biomarker for ovarian cancer using TCGA and GEO datasets
PeerJ
2021
Deep Genomic Sequencing of Bladder Urothelial Carcinoma in Southern Chinese Patients: A Single-Center Study
Frontiers in Oncology
2020
Alterations in TP53 Are a Potential Biomarker of Bladder Cancer Patients Who Benefit From Immune Checkpoint Inhibition
Cancer Control
2020
The Interplay between Oxidative Phosphorylation and Glycolysis as a Potential Marker of Bladder Cancer Progression
International Journal of Molecular Sciences
2020
Cell-penetrating peptides in oncologic pharmacotherapy: A review
Pharmacological Research
2020
Role of methyltransferase-like enzyme 3 and methyltransferase-like enzyme 14 in urological cancers
PeerJ
2020
A potential prognostic model based on miRNA expression profile in The Cancer Genome Atlas for bladder cancer patients
Journal of Biological Research-Thessaloniki
2020
RBM10, a New Regulator of p53
Cells
Additional cited-by details will be shown when available from Crossref